The ADMA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ADMA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ADMA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ADMA Detailed Price Forecast - CNN Money||View ADMA Detailed Summary - Google Finance|
|View ADMA Detailed Summary - Yahoo! Finance||View ADMA Stock Research & Analysis - Zacks.com|
|View ADMA Trends & Analysis - Trade-Ideas||View ADMA Major Holders - Barrons|
|View ADMA Call Transcripts - NASDAQ||View ADMA Breaking News & Analysis - Seeking Alpha|
|View ADMA Annual Report - CompanySpotlight.com||View ADMA OTC Short Report - OTCShortReport.com|
|View ADMA Fundamentals - TradeKing||View ADMA SEC Filings - Bar Chart|
|View Historical Prices for ADMA - The WSJ||View Performance/Total Return for ADMA - Morningstar|
|View the Analyst Estimates for ADMA - MarketWatch||View the Earnings History for ADMA - CNBC|
|View the ADMA Earnings - StockMarketWatch||View ADMA Buy or Sell Recommendations - MacroAxis|
|View the ADMA Bullish Patterns - American Bulls||View ADMA Short Pain Metrics - ShortPainBot.com|
|View ADMA Stock Mentions - StockTwits||View ADMA Stock Mentions - PennyStockTweets|
|View ADMA Stock Mentions - Twitter||View ADMA Investment Forum News - Investor Hub|
|View ADMA Stock Mentions - Yahoo! Message Board||View ADMA Stock Mentions - Seeking Alpha|
|View Insider Transactions for ADMA - SECform4.com||View Insider Transactions for ADMA - Insider Cow|
|View ADMA Major Holdings Summary - CNBC||View Insider Disclosure for ADMA - OTC Markets|
|View Insider Transactions for ADMA - Yahoo! Finance||View Institutional Holdings for ADMA - NASDAQ|
|View ADMA Stock Insight & Charts - FinViz.com||View ADMA Investment Charts - StockCharts.com|
|View ADMA Stock Overview & Charts - BarChart||View ADMA User Generated Charts - Trading View|
ADMA Biologics Upcoming PDUFA Dates and Milestones
Posted on Monday December 17, 2018
NEW YORK, NY / ACCESSWIRE / December 17, 2018 / Traders News Source, a leading independent equity research, and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on ADMA Biologics, Inc. (ADMA), a biopharmaceutical company that manufactures, markets and develops specialty plasma-based biologics for the treatment of Primary Immune Deficiency Disease and the prevention and treatment of certain infectious diseases. ADMA improved the U.S. Food and Drug Administration compliance status for its manufacturing facility in Boca Raton, Florida, which allowed it to submit applications for approval for the relaunch of BIVIGAM® and the approval and launch of RI-002.
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
Posted on Sunday December 16, 2018
Biotech stocks staged a modest comeback this week ending along with the broader market. The week saw a spate of clinical trial results releases , sending stocks moving in either direction. The tally of ...
Report: Developing Opportunities within Evelo Biosciences, ADMA Biologics, Karyopharm Therapeutics, Pingtan Marine Enterprise, Rosetta Stone, and Williams Companies — Future Expectations, Projections Moving into 2018
Posted on Tuesday November 13, 2018
NEW YORK, Nov. 13, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Adma Biologics: 3Q Earnings Snapshot
Posted on Thursday November 08, 2018
On a per-share basis, the Ramsey, New Jersey-based company said it had a loss of 33 cents. The results matched Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ...